
Aesthetics
Latest News

Latest Videos

Shorts










CME Content
More News

FDA clears SkinStylus microneedling for under-eye wrinkles in all skin types, expanding uses for acne and abdominal scars amid booming aesthetics demand.

Despite often being highly treatable, nonmelanoma skin cancers account for millions of biopsies, procedures, and follow-up visits annually, creating a substantial healthcare burden.

Do nighttime collagen masks actually work or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of June.

Q&A: Lisa Pruett, MD, FAAD, on Integrating Device-Based Therapies Into Comprehensive Acne Management
Lisa Pruett, MD, FAAD, shares evidence-based acne care, debunks summer retinoid myths, and explains how Glo2Facial oxygenation and exfoliation support clearer skin and fade marks.

Innovations in packaging, formulation design, and alternative preservation strategies may reduce preservative concentrations, but they are unlikely to eliminate the need for preservatives entirely.

In a pivotal trial, two-thirds of skinvive neck patients maintained clinically significant improvement at six months.

The FDA finalized the addition of bemotrizinol to the OTC sunscreen monograph, approving the broad-spectrum UV filter for use at concentrations up to 6% in adults and children 6 months or older.

Discover how tailored pre- and postmicroneedling care, plus lactobacillus exosome boosters, may speed healing, improve scars, and deliver safe, FDA-cleared results.

Michael Gold, MD, explains why the brand's microneedling pen stands out, with customizable depth, speed, and cartridges for rejuvenation and acne-scar treatment credibility.

Unlock hidden dermatology revenue by tracking retention drop-offs, procedure sequencing, and device utilization—before collections reveal the leaks.

Find out what skin care products and aesthetic innovations clinicians are recommending to patients for the month of May.

Prospective data presented at ASLMS by Isabella Camacho-Hubbard, MD, shows Stellar M22 XPL Glide boosts photodamage results, speeds treatments, avoids striping, and maintains safety.

Rapid GLP-1 weight loss can age the face—a new paper reviews multimodal nonsurgical fixes with fillers, Botox, devices, and skin care for natural balance.

Epicutis’ Hydrobiome Serum targets post-procedure barrier repair, while CEO Max Stock explains physician-guided care and biotech’s microbiome future.

Microbiome-first biotech in dermatology is shifting from harsh acne treatments to balance-focused solutions, using anti-inflammatory compounds that support healthier skin ecosystems.

The proposed rule, first introduced in 2015, aimed to prohibit indoor tanning for individuals under 18 because of the known cancer risks associated with UV radiation.

Data presented at SCALE 2026 showed that Ipsen’s investigational recombinant neuroinhibitor achieved significant and sustained improvement in moderate to severe glabellar lines.

Phages, or bacteriophages, are viruses that selectively infect bacteria and may offer a new way to treat bacterial skin diseases without antibiotics.

International experts set new skin care guidance for aesthetic procedures, detailing which actives speed healing, reduce irritation and PIH, and improve results.

Despite rapid market growth, many regenerative aesthetic products lack the rigorous nonclinical and clinical safety data that regulators typically require.

Turmeric and curcumin supplements used for hair loss are increasingly associated with rare but serious cases of liver injury.

Radiofrequency-assisted microneedling reduced both inflammatory and non-inflammatory lesions while promoting neocollagenesis and downregulating pro-inflammatory mediators.

Learn how narcissistic traits and body dysmorphia could shape cosmetic dermatology visits, with red flags, screening tips, and safer patient care.

The FDA has accepted the resubmitted BLA for relabotulinumtoxinA, a next-generation neuromodulator for treating facial lines in adults.



















